Write in a clean editor, then format for Egyptian Journal of Bronchology in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Egyptian Journal of Bronchology is a peer-reviewed journal published by Springer Nature, covering Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Pleural and Pulmonary Diseases.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. Egyptian Journal of Bronchology 12, 45–58 (2023).
Formats any DOI in Egyptian Journal of Bronchology style. No sign-up. |
| Publishes research in | Chronic Obstructive Pulmonary Disease (COPD) Research Respiratory Support and Mechanisms Pleural and Pulmonary Diseases Asthma and respiratory diseases Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| ISSN | 1687-8426 |
| Citation impact (2-yr) | 0.61 |
| h-index | 19 |
| i10-index | 59 |
| Total citations | 2,904 |
| Open access | Yes |
| Top institutions publishing here | Ain Shams University |
| Journal website | www.essbronchology.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract Background Being a newly emerging disease, little is known about its long-lasting post-COVID-19 consequences. The aim of this work is to assess the frequency, patterns, and determinants of persistent post-COVID-19 symptoms and to evaluate the value of a proposed novel COVID-19 symptom score. Patients with confirmed COVID-19 in a hospital-based registry were included in…
Abstract Background Coronavirus disease 2019 (COVID-19) was announced in early December 2019. The pandemic situation is declared. This study aimed to evaluate the role of biomarkers in estimating the severity and predicting the prognosis of COVID-19. Results A total of 116 confirmed patients were included in this study. The patients were evaluated clinically. The disease…
Abstract Background and objectives The role of interleukins in the severity and clinical profile of chronic obstructive pulmonary disease (COPD) is not known, but evidence supports the contribution of systemic inflammation to disease pathophysiology. This study evaluated the relationship of serum interleukin-6 (IL-6) to the severity and clinical parameters of COPD. Aim of work The…
To assess the diagnostic value of interleukin 6 (IL-6), IL-8 and tumor necrosis factor-α (TNF-α) as inflammatory markers in chronic obstructive pulmonary disease (COPD) patients. IL-6, IL-8 and TNF-α levels were measured by ELISA in the serum and the bronchoalveolar lavage (BAL) in 10 control participants and 25 mild and moderate COPD patients, whereas 25…
Abstract Background Being highly infectious disease, COVID-19 exhausts most of efficient healthcare systems worldwide. Simple and rapid risk stratification methods are mandatory to recognize severe patients. This study aims to highlight the simple available laboratory biomarkers of good predictive value for COVID-19 severity. Results Three hundred fifty-one COVID-19 positive patients admitted to two University Hospitals…
